Zyden Gentec Ltd.

View in App
0.94 ▼0%

17 April 2016, 04:36:52 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zydengentec.com
Market Cap 4.83 Cr.
Enterprise Value(EV) 6.84 Cr. 2019-03
Financial Indicators
Earnings per share (EPS) -0.68 Trailing Twelve Months Ending 2019-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2019-03
Industry PE 32.05 Trailing Twelve Months Ending 2019-03
Book Value / Share 2.38 Trailing Twelve Months Ending 2019-03
Price to Book Value 0.37 Calculated using Price: 0.87
Dividend Yield 0.00 Period Ending 2019-03
No. of Shares Subscribed 5.56 Cr. 55,562,000 Shares
FaceValue 2
About Zyden Gentec Ltd.
Zyden Gentec was incorporated on April 26, 1994 under the companies Act 1956 as Overseas Capital Private Limited. The name of the company was changed to Overseas Capital Limited on conversion into public limited company on November 11, 1994 and to Zyden Gentec Limited on July 16, 2004. The company was promoted by RK Dhar.

Zyden Gentec Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

No Deliveries found

Zyden Gentec Ltd. Performance

View details >>
1 Day
1 Week
+8.05%
1 Month
+8.05%
3 Month
+8.05%
6 Month
+8.05%
1 Year
+8.05%
2 Year
+8.05%
5 Year
+8.05%
10 Year
-85.63%

Zyden Gentec Ltd. Fundamental Ratios

View details >>
9 years 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03
Return on Equity (%) -1.27 -38.24 -5.71 -2.12 -0.34 -3.04 -0.11 -20.13 -47.91
Return on Capital Employed (%) 5.54 -14.83 -1.36 -0.99 -0.04 -1.75 -0.07 -3.36 -33.84
Return on Assets (%) -0.57 -16.80 -2.77 -1.04 -0.17 -1.65 -0.06 -12.27 -32.82

Zyden Gentec Ltd. Balance Sheet

View details >>
Particulars 10 years 2010-03 Rs. Cr. 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr.
Shh. Funds 9 9 13 13 12 12 12 12 10 6
Non Curr. Liab. 4 3 4 0 0 0
Curr. Liab. 3 10 9 14 12 11 9 9 5 2
Minority Int.
Equity & Liab. 16 22 26 26 24 24 21 21 15 8
Non Curr. Assets 4 9 11 9 8 8 16 16 10 7
Curr. Assets 11 13 16 17 16 15 5 5 5 1
Misc. Exp. not W/O
Total Assets 16 22 26 26 24 24 21 21 15 8

Zyden Gentec Ltd. Profit and Loss

View details >>
Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2015-12 Rs. Cr. TTM 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr.
Net Sales 12 10 8 2 0 0 0 1 1
Other Income 0 0 1 1 0 1 1 2
Total Income 12 10 8 3 1 1 1 0 3 1
Total Expenditure -11 -12 -9 -3 -1 0 -2 0 -3 -2
PBIDT 1 -3 0 0 0 1 0 0 -1 0
Interest -1 -1 0 0 0 0 -2
Depreciation 0 0 0 0
Taxation 0 0
Exceptional Items 0 -3
PAT 0 -4 -1 0 0 1 0 0 -2 -4
Adjusted EPS 0 -1 0 0 0 0 0 0 -1

Zyden Gentec Ltd. Cash Flow

View details >>
Particulars 10 years 2010-03 Rs. Cr. 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr.
Cash Fr. Operatn. 4 -2 -2 4 0 -2 -1 -5 0
Cash Fr. Inv. -5 -4 -6 0 1 0 2 1 5 2
Cash Fr. Finan. 1 6 8 -4 -2 0 0 0 -3
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Zyden Gentec Ltd. Shareholding Pattern

View details >>
9 Qtrs 2013-09 (%) 2013-12 (%) 2014-03 (%) 2014-06 (%) 2014-09 (%) 2014-12 (%) 2015-03 (%) 2015-06 (%) 2015-09 (%)
Promoter 6.62 2.25 2.28 2.28 2.27 0.00 0.00 0.00 0.00
Public 93.38 97.75 97.72 97.72 97.73 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Zyden Gentec Ltd. Announcements

View details >>
Tue, 29 Mar 2016
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Govinddas Daga has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mon, 22 Feb 2016
Financial Results for December 31, 2015
Zyden Gentec Ltd has informed BSE about :

1. Financial Results for the period ended December 31, 2015
Sat, 13 Feb 2016
Adjournment of Board Meeting
Zyden Gentec Ltd has informed BSE that the meeting of Board of Directors of the Company have been held on February 13, 2016, to transact the following business-

1. Due to some unavoidable circumstances the Board Of Directors have decided to postponed and adjourned the meeting for considerations and Approval of Un - Audited Financial Results of the Company for the Third Quarter ended on December 31, 2015to next Board Meeting to be held on February 22, 2016 at 3 P.M. at Registered office of the company.

2. Consider and took on records quarterly compliances under listing agreement and SEBI Regulations.

Zyden Gentec Ltd. Technical Scans

View details >>

No Scans Found

Zyden Gentec Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

Zyden Gentec Ltd. FAQ's

What is Zyden Gentec share price?
Can I buy Zyden Gentec shares now?
What is the Market Cap of Zyden Gentec?
What are the key metrics to analyse Zyden Gentec?